Panbela Therapeutics, Inc.
Records under this name other than the patents Panbela Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Panbela Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,529,326 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 11,925,613 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 12,350,246 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 10,973,790 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 11,591,286 | Methods for Producing (6S,15S)-3,8,13,18-Tetraazaicosane-6,15-DIOL Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,945,981 | Methods for Treating Familial Adenomatous Polyposis Formerly held In force · High confidence | In force | High confidence |